Insiders FUSN PHAR

Equities

FUSN

CA36118A1003

Real-time Estimate Cboe BZX Other stock markets 18:16:02 10/05/2024 BST			5-day change	1st Jan Change
21.38 ^USD	+0.02%		-0.19%	+122.79%

05-07	Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	TD Cowen Downgrades Fusion Pharmaceuticals to Hold	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fusion Pharmaceuticals Inc. Announces Board Changes	16/10/23	CI
Fusion Pharmaceuticals Appoints Dmitri Bobilev as Chief Medical Officer	07/11/22	CI
Fusion Pharmaceuticals Inc. Announces Executive Changes	13/04/22	CI
Insider Sell: Fusion Pharmaceuticals	08/03/22	MT
Insider Sell: Fusion Pharmaceuticals	17/02/22	MT
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development	10/01/22	PR
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development	10/01/22	CI
Fusion Pharmaceuticals Names Christopher Leamon as Chief Scientific Officer	03/11/21	MT
Fusion Pharmaceuticals Inc. Appoints Christopher Leamon as Chief Scientific Officer	02/11/21	CI
Fusion Pharmaceuticals : Names Mohit Rawat as President and Chief Business Officer	29/09/21	MT
Fusion Pharmaceuticals Appoints Mohit Rawat as President and Chief Business Officer	28/09/21	CI
Fusion Pharmaceuticals Inc. Appoints Eric S. Hoffman as Senior Vice President, Business Development	21/09/21	CI
Fusion Pharmaceuticals Inc. Appoints Isabelle Dussault as Senior Vice President, Research	07/06/21	CI
Fusion Pharmaceuticals Appoints Donald Bergstrom to Board of Directors	01/04/21	CI
Fusion Pharmaceuticals Appoints Philina Lee to Its Board of Directors	11/02/21	CI
Fusion Pharmaceuticals Inc. Appoints Barbara Duncan as Chairperson of the Board of Directors	02/11/20	CI
Fusion Pharmaceuticals Appoints Maria Stahl as Chief Legal Officer	29/09/20	CI
Fusion Pharmaceuticals Appoints James J. O’Leary, M.D. as Chief Medical Officer	23/03/20	CI
Fusion Pharmaceuticals Announces Appointment of Steven Gannon to Board of Directors and Chair of Audit Committee	04/03/20	CI
Fusion Pharmaceuticals Inc. Appoints Pablo J. Cagnoni, M.D., to Board of Directors	06/02/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders FUSN PHAR

Equities

FUSN

CA36118A1003

Insiders

Filters